Kontrol rapidly and efficiently reduces potassium in donor blood during ex vivo circulation.

Background: Patients with kidney failure are at risk for lethal complications from hyperkalemia. Resuscitation, medications, and hemodialysis are used to mitigate increased potassium (K) levels in circulating blood; however, these approaches may not always be readily available or effective, especially in a resource limited environment. We tested a sorbent cartridge (KC, Kontrol CytoSorbents Medical Inc., Monmouth Junction, New Jersey) which contains a resin adsorber for K. The objective of this study was to test the utility of KC in an ex vivo circulation system. We hypothesized that KC reduces K levels in extracorporeal circulation of donor swine whole blood infused with KCl.

Methods: A six-hour circulation study was carried out using KC, a NxStage (NxStage Medical, Inc., Lawrence, MA) membrane, blood bag containing heparinized whole blood with KCl infusion, 3/16-inch ID tubing, a peristaltic pump, and flow sensors. The NxStage permeate line was connected back to the main circuit in the Control group ( = 6), creating a recirculation loop. For KC group ( = 6), KC was added to the recirculation loop, and a continuous infusion of KCl at 10 mEq/hour was administered for two hours. Blood samples were acquired at baseline and every hour for 6 h.

Results: In the control group, K levels remained at ∼9 mmol/L; 9.1 ± 0.4 mmol/L at 6 h. In the KC group, significant decreases in K at hour 1 (4.3 ± 0.3 mmol/L) and were sustained for the experiment duration equilibrating at 4.6 ± 0.4 mmol/L after 6 h ( = 0.042). Main loop blood flow was maintained under 400 mL/min; recirculation loop flow varied between 60 and 70 mL/min in the control group and 45-55 mL/min in the KC group. Decreases in recirculation loop flow in KC group required 7% increase of pump RPM.

Conclusions: During ex-vivo extracorporeal circulation using donor swine blood, KC removed approximately 50% of K, normalizing circulating levels.